Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Awesome and thanks for the update! Also there is another interesting company called LabDoor (LabDoor.com) that ranks supplements based on quality and price by obtaining products from the shelves and reverse engineering them in FDA approved labs to see if companies are actually offering a product that does what it claims. The company was started by a guy who used to work for the FDA and they also have a retail option on the site where you can buy products from them. (Was featured on CNBC last week) This could be another good opportunity for the public to see just how high the quality is in the various products that inergetics manufactures...
CN, if you didn't have a chance to touch on it this time with Mr. James, maybe you can ask him next time. It's great that they are getting their products into brick and mortar stores and online retailers that mainly sell vitamins/supplements. But I think a huge potential retailer for the Surgex and Bikini Ready (and maybe even MS essentials) brands would be bodybuilding.com the online store is massive and has grown very rapidly in the last 5-10 years.
Also, I'm not here to bash, and I'm not calling out CN, but the reason I'm concerned is because of the general consensus that q1 is the best quarter of the year for this industry
Their cash position is very concerning to me. What happened to the NJ state money? Looks like a big chunk went straight to Martha Stewart for the royalty but where else? I was here before CBD but now I'm worried that its the only product with big money potential. The revenue numbers of under 500k was for all products and included Martha Stewart sales. In fact, The MS essentials have been on sale at my local walgreens for 9.99 since they started selling them...
Earnings numbers at the surface look very disappointing
Then why is Walmart planning to sell MJ in CO and WA starting this fall?
From TRTC board: Walmart plans to sell MJ and related products in CO and WA http://nationalreport.net/walmart-sell-marijuana-colorado-washington/
Today is also the first day CANN resumed trading... Bad day for the sector overall
Formulation is what NRTI is probably most concerned with considering the CBD team they've assembled. By having trtc control growth and extraction they give nrti the ability to formulate various supplements with various formulas that will be used to treat multiple specific medical issues that differ from each other, such as epilepsy, MS, and lupus. Think of nrti as the pharmaceutical company in this partnership. Trtc is the grower of different strains that will supply nrti with compounds of various levels of CBD that they can then formulate to treat a vast array of medical conditions. I see the partnership producing several different kinds of CBD supplements, not just one.
I strongly disagree with you that NRTI will always be one fifth of TRTC. While their partnership is significant, it is not the only business they are involved with. NRTI already has several brands of varying products in major retail stores around the country. These products are also on the cusp of making major progress toward making the company cash flow positive soon (as CN referenced with the pokers in the fire statement); similar to what the agriculture business has done for TRTC, but on a larger scale. I'm invested in both companies and am looking forward to what they accomplish this year. However they are not necessarily attached at the hip, yet.
Does it really matter? Pun intended, keep watching NRTI this year. 1.00 is very realistic.
Again not sure what planet you're on, put the bong down. Avg ten day vol is 458k.
Sorry *former CEO nvm
Also if anyone is curious, CEO of MSO up next on CNBC
I don't think we will see anything under .12 again, there's some good support that's been built. However, we could see .20+ very soon and then who knows from there, TRTC was under .10 not very long ago. Don't get too cute trying to time the market, you'll get burned every time. Lots of good news to come this year for both companies. I'm a big fan of both because of CEOs' abilities to diversify their business models and execute on all fronts.
LOL I think you're the one who needs to go do your DD
Did you know the US govt already has a patent on medical MJ? Great article if you want to learn more about medical MJ
http://www.cnn.com/2014/03/05/health/gupta-medical-marijuana/index.html?c=&page=1
Documentary next Tuesday on CNN may give a boost to the sector as a whole.
With Dr Shao already having pharmaceutical patents to his name this CBD partnership could turn out to be bigger than any of us can even imagine right now... Think about when Pfizer, Eli Lilly, etc move into this space when federal laws loosen...
NEWARK, N.J., March 5, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements today announced the appointment of Yu Shao, Ph.D., as a strategic member of their Scientific/Medical Advisory Board and advisor, guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements Inergetics and its partner Terra Tech (TRTC) are developing jointly.
Dr. Shao has extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.
Dr. Shao will work closely with Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN throughout the development process to ensure that the new CBD-based product lines are world-class in terms of medical effectiveness, quality, purity and safety.
"Given his deep experience in R&D, formulation and phytonutrient extraction methods, Dr. Shao is ideally qualified to provide strategic direction as an Advisory Board member as well as help us isolate and develop an innovative line of medical grade CBD-based nutritional supplements," said Carl Germano. "Dr. Shao has a proven record of successfully creating and launching new herbal, vitamin and medicinal products, and we very much look forward to working with him to bring to the market a range of CBD-based nutraceuticals offering relief to patients experiencing pain, nausea and other debilitative symptoms."
Dr. Shao has an impressive record of isolating and extracting new herbal, vitamin and pharmaceutical products to market. His recent experience includes eight product launches in eight years at Glaxo Smith Kline U.S. and 25 new products in four-plus years at Glaxo Smith Kline China. He has served in a range of senior R&D roles during his 13-year career at Glaxo Smith Kline, including Head of R&D for the Consumer Healthcare business in China; Group Leader/Director, New Weight Loss Product Development; Principal Scientist, Smoking Control/Pain Management; and Senior Development Scientist. Dr. Shao also served as Manager of Herbal and Vitamin R&D at Wyeth (now Pfizer) and as a Senior Scientist developing botanical extracts for dietary supplements at Pure World Botanicals. Additionally, he is the inventor and author of more than 60 pharmaceutical patents.
Dr. Shao received his Ph.D. in Natural Products Chemistry from the Shanghai Institute of Materia Medica, his M.A. in Organic Chemistry from Lanzhou University and his B.S. in Chemistry from Yangtze University. He also served as a Postdoctoral Fellow in Natural Products Chemistry at Rutgers University.
The strategic partnership between Inergetics and Terra Tech was announced on February 4th and the first CBD-based supplements are expected to be distributed via medicinal marijuana dispensaries.
Yeah, couldnt find much other than that which is why I asked. I know triage does distressed debt so these shares must be related to the restructuring that James has been actively doing. Any other info would be helpful; NRTI is one of 3-4 companies that Frenkel reported 9.99% ownership of on 12/31 and were made public by SEC on 2/14
does anyone know who Leonid Frenkel is? or Triage Capital? Sorry if I missed this, the form was filed middle of this month and he is a 9.99% owner of NRTI now?
http://www.sec.gov/Archives/edgar/data/72170/000091957414001458/d1452529_13g-a.htm
Granted, but they mentioned that 75% of their portfolio is enforceable outside the US which is a nice hedge against domestic uncertainty compared to other IP stocks. The line about their European litigation team was interesting as well.
I wouldn't mind a reversal on laches in the appellate court! What a journey this has been the last 1.5 years for me as I opened a scottrade account with money saved from my PE internship plus a loan from my dad after finding out about VRNG in the summer before my senior year of undergrad. I'm excited about the gains, but what I've learned throughout the process far exceeds the money. Much of that learning is due to your analysis and consistent pacer postings here and elsewhere. Thanks JJ, I hope I get to learn more from you in the future as I prepare for the LSAT in June!
People have been trying to time VRNG for two years now. No one cares about your pity party of not being able to find anything on the Internet or what your time horizon is. Try calling HJJ and asking him what he thinks if you can't find anything credible enough for yourself; or spend your time investing in all the quarterlies that have been coming out if you want a quick buck. You'll have better luck with both of those strategies rather than guessing the best time to get in and out of VRNG if last week wasn't a good enough time for you.
Lol right?? I think the problem is the news isn't reaching too many people
There are several catalysts and crooked has outlined them in the past. Closest on the horizon is actually receiving the cash after fees from the state of NJ expected this month. However if history repeats itself then none of these news events will carry much weight unless they are disseminated by an actual IR firm which is also supposed to be hired soon.
So without that, the next hard catalyst will be Q4 '13 10-Q where we have realized more of the projected record sales that began the last 15 days of Q3 '13. Also hopefully get some outlook on Q1 '14 performance.
Wouldn't be surprised to see this stock begin to appreciate without too much news at all as the public becomes more aware of its spec potential. Volume will be a good indicator of this since it is still amazingly low even though the stock continues to be accumulated.
Wow, thanks for your valuable insight! There's another lonely soul on the MSO board. I'm sure you guys can give each other plenty of attention that you need.
Agreed. They have potential for a strong business and James has done a good job of executing internal goals but they shouldn't forget shareholders either. If there is this much confusion over something that should be clear and simple, then it's no wonder that NRTIs share price has been dormant for so long. (I'm not bashing, Ive had a position for more than the last six months.)
Thanks Nutrition for the clarity, if one were to go back to the PR from the company on the 23rd they would see that NRTI does indeed call it a tax transfer program and says that this transaction is non dilutive and does not add any debt to capital structure...
NRTI lots of potential
Also on page 8
"The Company’s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing. Management believes they can raise the appropriate funds needed to support their business plan and develop an operating company which is cash flow positive."
I don't remember that bold part being in there in previous statements...hopefully they don't mean dilution though since Mr. James has been so outspoken against that.
The most positive part I could find is under Revenue Recognition on page 7:
"...Upon shipment to specific customers with the right of return the Company defers revenues as returns are not reasonably estimable. As of September 30, 2013, deferred revenue totaled $1,358,186."
So this revenue hasn't been recognized yet, but should be during this quarter. I'm hoping that coming PR's between now and then end of the year announcing new partnerships will help us glean some light on what kind of sales to expect in the coming quarters. 2014 should bring substantial sales growth quarter after quarter!
Completely agree. Maybe someone should write a SA article summarizing basically the intro page here. The problem is that people just don't even know about this company and the great things that are going on.
Thank you for correcting Ghart!
It seems that management is more focused on developing IP that can generate revenue now and licensing tomorrow as they stated in the CC. If you extrapolate the business backgrounds and history of the current management team it looks like their goal is not continuing patent litigation forever, but rather to build a business with incredibly valuable IP that will be acquired by someone else.
(http://www.bluecalypso.com/Pages/Informer/ManagementTeam.aspx)
Quick Summary of the CC:
They are not really saying anything at all about the infringement cases. One thing they did mention was that they are not revealing details of the settlements because the companies that have settled have requested them not to. They made it seem like they were happy about the settlements and wished they could give more info. They considered just being able to announce the 3.5% a "win" with respect to how much info they have to hold back.
Their 10Q will be released on or before Nov. 14
They are VERY excited about the core business they are developing with Blue Calypso Labs. They stated they already have revenue recorded that they will disclose in the 10Q and have a quickly growing deal flow that is being generated through their new partners. I'm paraphrasing but one of them said something along the lines of "we are excited about the deal flow our core business is generating, it's at the point where our partners are saying lets try these few projects first before we go on to more of them"
They said their burn rate is roughly $2K a month and the capital they just raised equates to $200K
After restructuring their debt, they now have about $60K in debt which is owed mostly to friends and family
Look at today AH http://www.nasdaq.com/symbol/nrti/after-hours
BCYP Business Update Presentation
http://www.bluecalypso.com/Pages/Informer/InvestorEvents.aspx
On Cardinal Health's website they talk about the number of store locations they serve, but I couldn't find anywhere about which companies the work with. Do you know where to get that info?
Also CN: I've read your posts from your conversations with Mr. James. Has he ever mentioned anything about TV ads or infomercials for the Martha Stewart Essentials?
Hi all, I've been following NRTI since the summer and got in about two months ago. Thanks to everyone here for all the great information you post. Are any of you concerned about the decreasing volume?